Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland
- First Online:
- Cite this article as:
- Lammi, N., Blomstedt, P.A., Moltchanova, E. et al. Diabetologia (2008) 51: 897. doi:10.1007/s00125-008-0952-9
To the Editor: Previously we reported data on trends in the incidence of type 1 and type 2 diabetes in Finnish young adults aged 15–39 years during 1992–1996  and found a 7.9% average annual increase in the incidence of type 2 diabetes. This rising trend needed to be confirmed during a longer period of follow-up, and therefore we extended the study until the year 2001.
The collection of data and the classification of patients with diabetes ascertained during 1992 to 1996 have been described in detail previously . The information on new diagnoses of diabetes in the age group of 15–39 years between 1997 and 2001 were obtained from three nationwide registers in Finland. The first register was the Drug Prescription Register of the Social Insurance Institute, which comprises ATC-DDD codes  on all prescriptions since 1994, and for this study all the class A10 drugs (drugs used in diabetes) were reviewed. The second register was the Drug Reimbursement Register of the Social Insurance Institute, which comprises information on persons entitled to free-of-charge medication for diabetes. The entitlement is given in response to an application that includes a detailed medical statement prepared by the treating physician. The third register was the Hospital Discharge Register, maintained by the National Research and Development Centre for Welfare and Health, which includes the treating physician’s diagnoses in ICD-10 codes .
Data from these registers were linked using the unique personal identification number assigned to every Finnish resident. The date of the first entry in any of these registers was set as the date of the diagnosis of diabetes. The patient had to be recorded in at least two of these registers to be included.
A patient was classified as having type 1 diabetes if two of the following three criteria were fulfilled: (1) an ICD-10 diagnosis referring only to type 1 diabetes; (2) permanent entitlement to free-of-charge medication; (3) only insulin was administered immediately at diagnosis and continued until the end of the year 2004.
A patient was classified as having type 2 diabetes if two of the following three criteria were fulfilled: (1) an ICD-10 diagnosis referring only to type 2 diabetes; (2) permanent or temporary entitlement to free-of-charge medication; (3) only oral glucose-lowering agents had been prescribed.
For patients who could not be reliably classified with this method, the application records for free-of-charge medication were acquired from the Social Insurance Institute and reviewed in order to assign the type of diabetes (n = 791). Information on patients with no entitlement to free-of-charge medication (n = 563) was reviewed, and most were classified as having gestational diabetes, as expected (persons with gestational diabetes are not entitled to free-of-charge medication). Patients who were impossible to classify as having type 1 or type 2 diabetes were classified as having an undefined type of diabetes.
The total number of patients who fulfilled the inclusion criterion for the years 1997–2001 was 4,062; of these patients, 434 with gestational diabetes and 131 with secondary forms of diabetes were excluded (American Diabetes Association criteria ). In total, 3,497 individuals aged 15–39 years were diagnosed with diabetes during 1997–2001. Of these, 48.3% (n = 1690) were classified as having type 1 diabetes and 36.3% (n = 1271) as having type 2 diabetes. For 15.3% (n = 536) the type of diabetes remained undefined. When the data from the years 1992–1996  were added to the data set, the total number of patients included in the analysis of the annual trend from 1992 to 2001 was 3,078 for type 1 diabetes and 2,392 for type 2 diabetes.
The sex- and age-specific incidences were calculated for 5-year age groups. Age-standardised annual incidence rates were calculated using the WHO standard European population with equal-sized age groups. The observed cases were assumed to result from a Poisson distribution, and 95% CIs were estimated using an exact method . The effect of year of diagnosis was assessed using Poisson regression with a logarithmic link function. The statistical analyses were performed using the R software .
The increasing trend of 3.9% per year in the incidence of type 1 diabetes in young adults was similar to the annual 4.2% increase in the incidence of type 1 diabetes in Finnish children . Thus, the trend previously observed in the child population seems to prevail among the Finnish young adult population also. In addition, the analysis confirms that the incidence of type 2 diabetes in Finnish young adults is increasing markedly. In the first half of this study (1992–1996) four data sources were utilised, whereas in the second analysis (1997–2001) we did not have the standardised forms filled in by diabetes nurses, which may have caused cases of type 2 diabetes to be dropped from the end of the study period. As this study was register-based, it could not take improved diagnostics into account and patients with type 2 diabetes treated without medication could not be captured by our method. However, the increasing incidence of type 2 diabetes in Finland is supported by the steep increase in the prevalence of the metabolic syndrome  in 24-year-old Finns.
The observed increase in the incidence of both type 1 and type 2 diabetes in Finnish young adults is alarming.
This work was funded by the National Institutes of Health (grant DK062374–01A1) and the Academy of Finland (grants 207008 and 214111).
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.